1. American Joint Committee on Cancer, in Beahrs OH, Henson DE, Hutter RVP, Myers MH (eds): Manual for Staging of Cancer. 3rd ed. Philadelphia, Lippincott, 1988, pp 81–83.
2. Boman BM, Moertel CG, O’Connell MJ, Scott N, Weiland LH, Beart RW, Gunderson LL, Spencer RJ: Carcinoma of the anal canal: A clinical and pathologic study of 188 cases. Cancer 1984;54:114–125.
3. Brunet R, Bécouarn Y, Pigneux J, Revaud A, Faivre J, Jeandroz V: Cisplatine et fluoro-uracile en chimiothérapie neoadjuvante des carcinomas épidermoides du canal anal. Lyon Chir 1990;87:77–78.
4. Buroker TR, Nigro N, Bradley G: Combined therapy for cancer of the anal canal: a follow up report. Dis Colon Rectum 1977;20:677–678.
5. Byfield JE, Barone RM, Sharp TR, Frankel SS: Conservative management without alkylating agents of squamous cell anal cancer using cyclical 5FU alone and x-ray therapy. Cancer Treat Rep 1983;67:709–712.